Chronic urticaria: Omalizumab and review of therapeutic options

Journal of Drugs in Dermatology

Volumn 12, Issue 6, 2013, Pages 715-716

  Bergstrom, Kendra Gail ^a  

^a Island Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; OMALIZUMAB; ZAFIRLUKAST;

ASTHMA; CHRONIC URTICARIA; HUMAN; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); SHORT SURVEY; TREATMENT PLANNING;

ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; HUMANS; URTICARIA;

EID: 84878667879     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol. 1996 May;106(5):1001-6. (Pubitemid 26153503)
2. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol. 1985 Apr;12(4):669-75. (Pubitemid 15106044)
3. Bressler RB, Sowell K, Huston DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol. 1989 Apr;83(4):756-63. (Pubitemid 19127941)
4. Khan S, Lynch N. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria. Inflamm Allergy Drug Targets. 2012 Jun;11(3):235-43.
5. Zimmerman AB, Berger EM, Elmariah SB, Soter NA. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. J Am Acad Dermatol. 2012 May;66(5):767-70.
6. Trojan TD, Khan DA.Calcineurin inhibitors in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):412-20.
7. Briggs GD, Freeman RK. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk 2008. Eighth edition. Lippincott and Williams Publications; 2008-2117.
8. Watson NT, Weiss EL, Harter PM.Famotidine in the treatment of acute urticaria. Clin Exp Dermatol. 2000 May;25(3):186-9. (Pubitemid 30340542)
9. Ogawa Y, Ishinokawa Y, Hiruma M, Machida Y, Funakushi N, Hiruma M.Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria. J Dermatolog Treat. 2013 May 3
10. Kosnik M, Subic T. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria. Respir Med. 2011 Oct;105 Suppl 1:S84-8.
11. Maurer M, Rosén K, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 7;368(10):924-35.